Physician profile
David Downs
NPI 1023101375
$9,707.99
in general payments reported to CMS, 2019-2025
14 companies · $1,393 in 2025
The $1,393 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $23.14 · 2021: $2,975 · 2022: $2,289 · 2023: $2,742 · 2024: $157 · 2025: $1,393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,151 · Travel and Lodging: $2,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,151.18 |
| Travel and Lodging | $2,140.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Empire Medical, INC | $4,612.19 | 2021-2023 | |
| Arthrex, INC. | $4,232.68 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $218.98 | 2019-2025 | Rosa |
| Abbott Laboratories | $202.86 | 2023-2024 | Proclaim, Eterna |
| Vericel Corporation | $126.23 | 2019-2024 | Maci |
| Vital Orthopedics LLC | $111.51 | 2025 | |
| Stryker Corporation | $41.79 | 2019-2021 | |
| Dynasplint Systems INC. | $39.50 | 2019 | |
| Boston Scientific Corporation | $39.23 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic USA, INC. | $21.37 | 2020 | |
| Forte Bio-Pharma LLC | $20.34 | 2019-2020 | |
| Depuy Synthes Sales INC. | $16.77 | 2023 | Orthovisc |
| Globus Medical, INC. | $14.54 | 2022 | |
| Heraeus Medical, LLC. | $10.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Downs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.